GlassScriptPrepare for your visit
Dinesh Chinthagada
Interventional Pain Medicine · Evergreen Park, IL · NPI 1699702753
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$2,517.94
in general payments reported to CMS, 2019-2025 · $633 in 2025
The $633 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Who reported paying
General payments only, top 6 by amount.
- Abbott Laboratories $1,316.90
- Vertos Medical, INC. $494.78
- Boston Scientific Corporation $321.99
- Nalu Medical, INC. $132.39
- Medtronic, INC. $61.29
- Astrazeneca Pharmaceuticals LP $45.06
Drugs and devices associated with these payments
Proclaim Prodigy Mild Device Kit Nalu Neurostimulation System Farxiga Nayzilam Inceptiv Journavx Kyphon Express II Kyphopak Tray General - Therapies Gelsyn-3 Rs 4i Plus Sequential Stimulator
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Dinesh Chinthagada listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/303659/dinesh-chinthagada